Pharmacology in the Era of Targeted Therapies: The Case of PI3K Inhibitors

Por Toska, Eneda, Baselga, José
Publicado no Clin Cancer Res (2016)

Targeted therapies for breast cancer

Por Higgins, Michaela J., Baselga, José
Publicado em 2011

Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy

Por Scaltriti, Maurizio, Elkabets, Moshe, Baselga, José
Publicado no Clin Cancer Res (2016)

Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors

Por Carracedo, Arkaitz, Baselga, Jose, Pandolfi, Pier Paolo
Publicado em 2008

Treatment of HER2-Positive Metastatic Breast Cancer

Por Swain, Sandra M., Clark, Emma, Baselga, José
Publicado no N Engl J Med (2015)

Implementing Genome-Driven Oncology

Por Hyman, David M., Taylor, Barry S., Baselga, José
Publicado no Cell (2017)

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism

Por Fuentes, Gloria, Scaltriti, Maurizio, Baselga, José, Verma, Chandra S
Publicado em 2011

Advances in the management of HER2-positive early breast cancer

Por Baselga, José, Coleman, Robert E., Cortés, Javier, Janni, Wolfgang
Publicado no Crit Rev Oncol Hematol (2017)

Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs

Por Osmanbeyoglu, Hatice U., Toska, Eneda, Chan, Carmen, Baselga, José, Leslie, Christina S.
Publicado no Nat Commun (2017)

Unconventional Secretion is a Major Contributor of Cancer Cell Line Secretomes

Por Villarreal, Laura, Méndez, Olga, Salvans, Cándida, Gregori, Josep, Baselga, José, Villanueva, Josep
Publicado em 2013

The Carboxy-terminal Cysteine of the Tetraspanin L6 Antigen Is Required for Its Interaction with SITAC, a Novel PDZ Protein

Por Borrell-Pagès, Maria, Fernández-Larrea, Juan, Borroto, Aldo, Rojo, Federico, Baselga, José, Arribas, Joaquín
Publicado em 2000

The tumor suppressor PTEN and the PDK1 kinase regulate formation of the columnar neural epithelium

Por Grego-Bessa, Joaquim, Bloomekatz, Joshua, Castel, Pau, Omelchenko, Tatiana, Baselga, José, Anderson, Kathryn V
Publicado no eLife (2016)

AKT signaling in ERBB2-amplified breast cancer

Por Carmona, F Javier, Montemurro, Filippo, Kannan, Srinivasaraghavan, Rossi, Valentina, Verma, Chandra, Baselga, José, Scaltriti, Maurizio
Publicado no Pharmacol Ther (2015)

Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis

Por Bech-Serra, Joan J., Santiago-Josefat, Belén, Esselens, Cary, Saftig, Paul, Baselga, José, Arribas, Joaquín, Canals, Francesc
Publicado em 2006

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation

Por Anido, Judit, Scaltriti, Maurizio, Bech Serra, Joan Josep, Josefat, Belén Santiago, Rojo Todo, Federico, Baselga, José, Arribas, Joaquín
Publicado em 2006

Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance

Por Wehrenberg-Klee, Eric, Turker, N. Selcan, Heidari, Pedram, Larimer, Benjamin, Juric, Dejan, Baselga, José, Scaltriti, Maurizio, Mahmood, Umar
Publicado no J Nucl Med (2016)

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-cont...

Por Miles, David, Baselga, José, Amadori, Dino, Sunpaweravong, Patrapim, Semiglazov, Vladimir, Knott, Adam, Clark, Emma, Ross, Graham, Swain, Sandra M.
Publicado em 2013

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial

Por Bonner, James, Giralt, Jordi, Harari, Paul, Spencer, Sharon, Schulten, Jeltje, Hossain, Anwar, Chang, Shao-Chun, Chin, Steve, Baselga, José
Publicado no JAMA Otolaryngol Head Neck Surg (2016)

TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS

Por Raina, Deepak, Uchida, Yasumitsu, Kharbanda, Akriti, Rajabi, Hasan, Panchamoorthy, Govind, Jin, Caining, Kharbanda, Surender, Scaltriti, Maurizio, Baselga, Jose, Kufe, Donald
Publicado em 2013

Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer

Por Prat, Aleix, Carey, Lisa A., Adamo, Barbara, Vidal, Maria, Tabernero, Josep, Cortés, Javier, Parker, Joel S., Perou, Charles M., Baselga, José
Publicado em 2014